WeInfuse Press

Welcome to the WeInfuse Press Page. If it involves WeInfuse press or any Infusion Center article we feel is worth reading, we will post it here for your enjoyment.

Published in Becker's Hospital Review | August 18, 2017 | Written by Bryan Johnson and Judy Back, RN 

If you’re a neurologist, you can’t ignore the question: should I open an Infusion Center? And, if you have an Infusion Center, you’re asking yourself: Am I running my Infusion Center optimally and according to best practices?

With Tysabri already on the shelf, the launch of Lemtrada in late 2014, the recent launch of Ocrevus and the robust pipeline of specialty neuro infusion medications such as Radicava for ALS and the various Alzheimer’s medications, you can’t ignore how infusion is shaping the neuro space. Indeed, these specialty

The startup emerged from stealth mode earlier this year and already counts a couple of clinics around the country as clients. With financial backing from prominent names in the Austin tech scene, WeInfuse's founders say their software can make life-saving therapies available to all sizes of medical clinics.

Read the ABJ article here: Austin Business Journal
(must be a subscriber to view the entire article)

AUSTIN, Texas, March 8, 2017 /PRNewswire/ -- For persons living with multiple sclerosis, Crohn's Disease, rheumatoid arthritis or Lupus, easy access to their life-changing medications and treatments is critical to their quality of life. To help specialty physicians and independent Infusion Centers provide the best care to these patients, entrepreneurs and infusion center owners Reece Norris and Bryan Johnson developed WeInfuse, the first web-based software that improves the operations and administration of specialty and biologic pharmaceuticals needed by millions of patients each year.

WeInfuse helps doctors, nurses and administrators by coordinating patient scheduling and insurance pre-authorization as well as inventory and

Originally published in the Washington Times / Opinion / Commentary Page
http://www.washingtontimes.com/news/2016/sep/19/wrecking-the-economics-of-medicare-drugs/

Washington bean counters don’t set the prices of houses or vehicles. Buyers and sellers settle on mutually agreeable prices. That’s why there isn’t a nationwide shortage of duplexes or jeeps.

Evidently, our unelected officials at the Centers for Medicare and Medicaid Services slept through Economics 101. They’re about to set Medicare drug reimbursements so low that hundreds of local clinics — the “sellers” of medical services — will have little choice but to refuse to treat their patients or risk going out of business altogether. Patients with Crohn’s disease, rheumatoid arthritis,

Originally Published in the Austin American Statesman
http://www.mystatesman.com/news/opinion/nyquist-medicare-cuts-are-wrong-for-those-with-rheumatoid-arthritis/BndtzDJdnnNtLhEAoEkXJL/

More than 1.5 million Americans are living with rheumatoid arthritis.

A diagnosis is life altering, as RA causes chronic swelling and pain and increases the risk of heart attack, stroke, and depression. After learning they have the disease, many patients head to their local Infusion Center for treatment, as many of the best medicines for RA are delivered intravenously.

But if Medicare officials in Washington proceed with a new plan to cut Medicare funding, many of these centers will close or be forced to turn away patients who need these advanced treatments. This proposal, which impacts